P1.01-45 Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey - Turhal, N. S.; Saadettin Kılıçkap; Üskent, Necdet; Akın Öztürk; Nuri Karadurmuş; Taner Korkmaz; Perran Fulden Yumuk; İ. Çiçin; Semra Paydaş; Ebru Çılbır; Teoman Şakalar; Mükremın Uysal; et al. (My University, 2018)
Keywords: Crizotinib; Medicine; Internal medicine; Lung cancer; Stage (stratigraphy); ALK inhibitor; Adenocarcinoma; Medical record; Oncology; Gastroenterology; Cancer